Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Alopecia areata mainly affects young people and has significant psychological impacts, especially in males.

The document says current treatments for alopecia areata do not cure or prevent it, and it's hard to judge their effectiveness due to spontaneous remission and lack of studies.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Alopecia areata in these mice is inherited, more common in young females, and can be treated with triamcinolone acetonide.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Current treatments for alopecia show no significant long-term benefits.

Alopecia areata is caused by the immune system attacking hair follicles.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Scalp dermoscopy is good for diagnosing a type of hair loss and helps choose the best spots for biopsy.

Baricitinib was effective in treating alopecia areata in two major trials.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Topical sensitizers have mixed success in treating alopecia areata.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.